✦ LIBER ✦
7000 ORAL A phase I/II study to determine the feasibility and efficacy of the triple combination of Oblimersen (OBL), Abraxane (ABX), and Temozolomide (TMZ) in metastatic melanoma
✍ Scribed by Pavlick, A.; Volm, M.; Ryan, T.; Escalon, J.; Lee, L.; Liebes, L.
- Book ID
- 122082445
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 56 KB
- Volume
- 5
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.